Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer
出版年份 2022 全文链接
标题
Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer
作者
关键词
ovarian cancer, IDG-VEGF, relapsed/MDR model, microRNA-Let7b, hyaluronic-acid-based nanoparticles
出版物
Molecular Therapy-Oncolytics
Volume 25, Issue -, Pages 57-68
出版商
Elsevier BV
发表日期
2022-03-16
DOI
10.1016/j.omto.2022.03.005
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Improved anti-tumor efficacy of paclitaxel in combination with MicroRNA-125b-based tumor-associated macrophage repolarization in epithelial ovarian cancer
- (2019) Neha N. Parayath et al. CANCER LETTERS
- Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo
- (2019) Meirav Segal et al. Molecular Therapy-Nucleic Acids
- Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
- (2018) Venus Dalal et al. CLINICA CHIMICA ACTA
- Repolarization of Tumor-Associated Macrophages in a Genetically Engineered Nonsmall Cell Lung Cancer Model by Intraperitoneal Administration of Hyaluronic Acid-Based Nanoparticles Encapsulating MicroRNA-125b
- (2018) Neha N. Parayath et al. NANO LETTERS
- Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
- (2017) Man Xiao et al. Journal of Ovarian Research
- MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
- (2017) Malav Trivedi et al. Scientific Reports
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis
- (2016) Li Gong et al. BIOMEDICINE & PHARMACOTHERAPY
- Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer
- (2016) Pradeep Chaluvally-Raghavan et al. Cell Reports
- MicroRNA-223 Induced Repolarization of Peritoneal Macrophages Using CD44 Targeting Hyaluronic Acid Nanoparticles for Anti-Inflammatory Effects
- (2016) Thanh-Huyen Tran et al. PLoS One
- Combinatorial Action of MicroRNAslet-7and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
- (2015) Carlos Stahlhut et al. CELL CYCLE
- MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1
- (2015) Ke Niu et al. GENE
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
- (2015) Xiaoqian Yang et al. Scientific Reports
- LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b
- (2014) Yuan Gao et al. HUMAN MOLECULAR GENETICS
- A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
- (2014) A L Kasinski et al. ONCOGENE
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer
- (2014) Xiaoqian Yang et al. PHARMACEUTICAL RESEARCH
- Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
- (2013) Shanthi Ganesh et al. BIOMATERIALS
- In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
- (2013) Shanthi Ganesh et al. JOURNAL OF CONTROLLED RELEASE
- Diverse functions of miR-125 family in different cell contexts
- (2013) Yu-Meng Sun et al. Journal of Hematology & Oncology
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
- (2013) Shanthi Ganesh et al. Molecular Therapy-Nucleic Acids
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications
- (2009) Delia Mezzanzanica et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Identification of Let-7-Regulated Oncofetal Genes
- (2008) B. Boyerinas et al. CANCER RESEARCH
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started